In the context of tumours, a large number of Treg cells were often detected, which inhibited or reduced these effector lymphocytes, such as CD4+ T cells and CD8+ cytotoxicity T lymphocytes (CTL), achieving antitumour immune responses [43–45]. This evidence concerns the gene CD4 and neoplasm.